Literature DB >> 18458969

Evidence of a founder haplotype refines the X-linked Charcot-Marie-Tooth (CMTX3) locus to a 2.5 Mb region.

Megan Brewer1, Febriani Changi, Anthony Antonellis, Kurt Fischbeck, Patsie Polly, Garth Nicholson, Marina Kennerson.   

Abstract

X-linked Charcot-Marie-Tooth (CMTX) disease is a common inherited degenerative disorder of the peripheral nerve. Previously, our laboratory identified a large New Zealand/United Kingdom (NZ/UK) family mapping to the CMTX3 locus (Xq26.3-27.1). We have now identified a second large, Australian X-linked CMT family that links to the CMTX3 locus. This new family has the same phenotype as our previously described CMTX3 family, with slightly milder disease in males than CMTX1 and asymptomatic carrier females. This study also includes the re-analysis of one of the original US pedigrees reporting the CMTX3 locus. The large Australian family shared the complete disease haplotype with our original NZ/UK family, while the American family shared only the distal portion of the disease haplotype. Comparison of the frequency of the CMTX3 haplotype to the normal population showed strong statistical evidence (p < 0.0001) indicating that the smaller shared haplotype is identical by descent. This suggests that the new CMTX3 family, our previously reported family, and the original American CMTX3 family have a common ancestor, and the disease in these families is caused by a founder mutation. The ancestral recombination observed in the American family refines the CMTX3 interval to a 2.5 Mb region between DXS984 and DXS8106. In this region, 11 out of the 15 annotated genes have been excluded for pathogenic mutations.

Entities:  

Mesh:

Year:  2008        PMID: 18458969      PMCID: PMC6852654          DOI: 10.1007/s10048-008-0126-4

Source DB:  PubMed          Journal:  Neurogenetics        ISSN: 1364-6745            Impact factor:   2.660


  14 in total

1.  A clinical, electrophysiologic, neuropathologic, and genetic study of two large Algerian families with an autosomal recessive demyelinating form of Charcot-Marie-Tooth disease.

Authors:  M Kessali; R Zemmouri; A Guilbot; T Maisonobe; A Brice; E LeGuern; D Grid
Journal:  Neurology       Date:  1997-04       Impact factor: 9.910

2.  Genetic and clinical aspects of Charcot-Marie-Tooth's disease.

Authors:  H Skre
Journal:  Clin Genet       Date:  1974       Impact factor: 4.438

3.  Study on the gene and phenotypic characterisation of autosomal recessive demyelinating motor and sensory neuropathy (Charcot-Marie-Tooth disease) with a gene locus on chromosome 5q23-q33.

Authors:  A Gabreëls-Festen; S van Beersum; L Eshuis; E LeGuern; F Gabreëls; B van Engelen; E Mariman
Journal:  J Neurol Neurosurg Psychiatry       Date:  1999-05       Impact factor: 10.154

4.  Faster sequential genetic linkage computations.

Authors:  R W Cottingham; R M Idury; A A Schäffer
Journal:  Am J Hum Genet       Date:  1993-07       Impact factor: 11.025

5.  Heterogeneity in X-linked recessive Charcot-Marie-Tooth neuropathy.

Authors:  V V Ionasescu; J Trofatter; J L Haines; A M Summers; R Ionasescu; C Searby
Journal:  Am J Hum Genet       Date:  1991-06       Impact factor: 11.025

6.  Proof of genetic heterogeneity in X-linked Charcot-Marie-Tooth disease.

Authors:  I G Huttner; M L Kennerson; S W Reddel; D Radovanovic; G A Nicholson
Journal:  Neurology       Date:  2006-12-12       Impact factor: 9.910

7.  The p.R1109X mutation in SH3TC2 gene is predominant in Spanish Gypsies with Charcot-Marie-Tooth disease type 4.

Authors:  R Claramunt; T Sevilla; V Lupo; A Cuesta; J M Millán; J J Vílchez; F Palau; C Espinós
Journal:  Clin Genet       Date:  2007-04       Impact factor: 4.438

8.  Strategies for multilocus linkage analysis in humans.

Authors:  G M Lathrop; J M Lalouel; C Julier; J Ott
Journal:  Proc Natl Acad Sci U S A       Date:  1984-06       Impact factor: 11.205

9.  Mutations in PRPS1, which encodes the phosphoribosyl pyrophosphate synthetase enzyme critical for nucleotide biosynthesis, cause hereditary peripheral neuropathy with hearing loss and optic neuropathy (cmtx5).

Authors:  Hee-Jin Kim; Kwang-Min Sohn; Michael E Shy; Karen M Krajewski; Miok Hwang; June-Hee Park; Sue-Yon Jang; Hong-Hee Won; Byung-Ok Choi; Sung Hwa Hong; Byoung-Joon Kim; Yeon-Lim Suh; Chang-Seok Ki; Soo-Youn Lee; Sun-Hee Kim; Jong-Won Kim
Journal:  Am J Hum Genet       Date:  2007-06-29       Impact factor: 11.025

10.  Connexin mutations in X-linked Charcot-Marie-Tooth disease.

Authors:  J Bergoffen; S S Scherer; S Wang; M O Scott; L J Bone; D L Paul; K Chen; M W Lensch; P F Chance; K H Fischbeck
Journal:  Science       Date:  1993-12-24       Impact factor: 47.728

View more
  4 in total

1.  X-linked CMT: genes and gene loci in an Australian cohort.

Authors:  Megan Hwa Brewer; Rabia Chaudhry; Keta McDowall; Shannon Chu; Bartosz Kowalski; Patsie Polly; Garth Nicholson; Marina Kennerson
Journal:  Neurogenetics       Date:  2010-03-05       Impact factor: 2.660

2.  A new locus for X-linked dominant Charcot-Marie-Tooth disease (CMTX6) is caused by mutations in the pyruvate dehydrogenase kinase isoenzyme 3 (PDK3) gene.

Authors:  Marina L Kennerson; Eppie M Yiu; David T Chuang; Aditi Kidambi; Shih-Chia Tso; Carolyn Ly; Rabia Chaudhry; Alexander P Drew; Gary Rance; Martin B Delatycki; Stephan Züchner; Monique M Ryan; Garth A Nicholson
Journal:  Hum Mol Genet       Date:  2013-01-07       Impact factor: 6.150

3.  Re-analysis of an original CMTX3 family using exome sequencing identifies a known BSCL2 mutation.

Authors:  Rabia Chaudhry; Aditi Kidambi; Megan Hwa Brewer; Anthony Antonellis; Katherine Mathews; Garth Nicholson; Marina Kennerson
Journal:  Muscle Nerve       Date:  2013-03-29       Impact factor: 3.217

4.  Whole Genome Sequencing Identifies a 78 kb Insertion from Chromosome 8 as the Cause of Charcot-Marie-Tooth Neuropathy CMTX3.

Authors:  Megan H Brewer; Rabia Chaudhry; Jessica Qi; Aditi Kidambi; Alexander P Drew; Manoj P Menezes; Monique M Ryan; Michelle A Farrar; David Mowat; Gopinath M Subramanian; Helen K Young; Stephan Zuchner; Stephen W Reddel; Garth A Nicholson; Marina L Kennerson
Journal:  PLoS Genet       Date:  2016-07-20       Impact factor: 5.917

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.